Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19

enthalten in: bioRxiv.org | 2021

von Baker, J. | Mahdi, M. | Nicolau, D. | +7

Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity

enthalten in: bioRxiv.org | 2021

von Garry, E. | Weckstein, A. | Quinto, K. | +7

Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2 infected Pakistani Patients

enthalten in: bioRxiv.org | 2021

von Omer, S. | Sarwar, M. | Roman, M. | +10

Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19

enthalten in: bioRxiv.org | 2021

von Pan, D. | Kim, J. | Nazareth, J. | +16

Deleterious drugs in COVID-19: a rapid systematic review and meta-analysis

enthalten in: bioRxiv.org | 2021

von Holder, M. | Heeney, C. | Malden, S. | +2

Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study

enthalten in: bioRxiv.org | 2021

von Swann, O. | Pollock, L. | Holden, K. | +22

A randomized controlled trial of inhaled ciclesonide for outpatient treatment of symptomatic COVID-19 infections

enthalten in: bioRxiv.org | 2021

von Clemency, B. | Varughese, R. | Gonzalez-Rojas, Y. | +4

Long-term corticosteroid therapy for patients with severe coronavirus disease 2019 (COVID-19)

enthalten in: bioRxiv.org | 2021

von Calcaianu, G. | Degoul, S. | Payen, T. | +5

Clinical features, demography and predictors of outcomes of SARS-CoV-2 infection in a tertiary care hospital in India-A cohort study

enthalten in: bioRxiv.org | 2021

von Elavarasi, A. | Raju Sagiraju, H. | Garg, R. | +30

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalized patients with COVID-19: A network meta-analysis

enthalten in: bioRxiv.org | 2021

von Godolphin, P. | Fisher, D. | Berry, L. | +10